US Patent Issued to PeptiDream on Sept. 16 for "GhR-binding peptide and composition comprising same" (Japanese Inventors)

ALEXANDRIA, Va., Sept. 17 -- United States Patent no. 12,415,834, issued on Sept. 16, was assigned to PeptiDream Inc. (Kanagawa, Japan).

"GhR-binding peptide and composition comprising same" was invented by Tatsuya Tomiyama (Kanagawa, Japan), Haruaki Kurasaki (Kanagawa, Japan), Katsuma Matsui (Kanagawa, Japan), Yoshiaki Masuda (Kanagawa, Japan) and Masataka Umitsu (Kanagawa, Japan).

According to the abstract* released by the U.S. Patent & Trademark Office: "The present technology generally relates to peptides that bind to the growth hormone receptor (GhR), to peptides that bind to the GhR and have antagonistic activity, and to compositions comprising such peptides."

The patent was filed on June 17, 2022, under Application No. 17/842,953....